GPT and metabolic dysfunction-associated steatotic liver disease: Disorders of lipid metabolism, such as obesity and nonalcoholic fatty liver disease, can lead to abnormal elevation of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT).